ANDA 209424, held by Torrent. Solifenacin Succinate.
As of Nov 16, 2026, ANDA 209424 (Solifenacin Succinate), held by Torrent, was first approved by FDA on Mar 4, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 4, 2025 | Original application | Approved | None posted |
| Solifenacin Succinate5MG · tablet;oral | Solifenacin Succinate | Discontinued |
| Solifenacin Succinate10MG · tablet;oral | Solifenacin Succinate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters